BlackRock Health Sciences Term Trust (NYSE: BMEZ)
Financials · Capital Markets · US
$17.04
+0.41% today · +19.4% 1Y
BlackRock Health Sciences Term Trust (NYSE: BMEZ) operates in the Capital Markets industry within the Financials sector. The company is valued at $1.07B.
Over the last twelve months the share price has gained 19.4%, trading between 13.70 and 17.25.
Tweenvest scores BlackRock Health Sciences Term Trust across four factors: dividend 90/100. Its strongest factor is dividend.
BMEZ price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.07B
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- 7.96%
- Beta (5Y)
- 0.84
- 52-week high
- $17.25
- 52-week low
- $13.70
- Avg volume (3M)
- —
- Shares outstanding
- 62.50M
- Employees
- —
- Next earnings
- —
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Term Trust is a closed-end management investment company, which investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The company was founded on August 14, 2019 and is headquartered in Wilmington, DE.
- Listed since
- Jan 29, 2020
- Exchange
- New York Stock Exchange
- Currency
- USD
Other Capital Markets companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETFARCA: VTI | $2.31T | $378.24 | +0.44% |
| Vanguard Index Funds - Vanguard S&P 500 ETFARCA: VOO | $1.66T | $703.71 | +0.39% |
| iShares Trust - iShares Core S&P 500 ETFARCA: IVV | $893.67B | $769.31 | +0.39% |
| State Street SPDR S&P 500 ETF TrustARCA: SPY | $821.60B | $765.72 | +0.41% |
| Invesco QQQ Trust, Series 1NasdaqGM: QQQ | $487.14B | $713.44 | +0.36% |
| Vanguard Index Funds - Vanguard Morningstar Growth ETFARCA: VUG | $378.44B | $87.50 | +0.38% |
| Morgan StanleyNYSE: MS | $336.42B | $214.20 | +3.25% |
| The Goldman Sachs Group, Inc.NYSE: GS | $314.66B | $1,039.28 | +3.73% |
Figures last refreshed Aug 18, 2026.